Effectiveness of OZ439 Against Early Plasmodium Falciparum Blood Stage Infection in Healthy Volunteers
Status:
Completed
Trial end date:
2013-03-01
Target enrollment:
Participant gender:
Summary
A single centre, open, controlled study using Blood Stage Plasmodium falciparum challenge
inoculum (BSPC) as a model to assess the effectiveness of three dose levels of the
experimental anti-malarial product, OZ439.